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ABSTRACT 
The plant pathogenic bacterium Ralstonia 
solanacearum injects more than 70 effector 
proteins (virulence factors) into the host plant cells 
via the needle-like structure of a type III secretion 
system (T3SS).  The T3SS effector proteins 
manipulate host regulatory networks to suppress 
defense responses with diverse molecular 
activities.  Uncovering the molecular function of 
these effectors is essential for a mechanistic 
understanding of R. solanacearum pathogenicity.  
However, few of the effectors from R. 
solanacearum have been functionally 
characterized and their plant targets remain largely 
unknown.  Here, we show that the ChaC-domain 
containing effector RipAY/RSp1022 from R. 
solanacearum exhibits γ-glutamyl 
cyclotransferase (GGCT) activity to degrade the 
major intracellular redox buffer, glutathione.   
Heterologous expression of RipAY, but not other 
ChaC family proteins conserved in various 
organisms caused growth inhibition to yeast 
Saccharomyces cerevisiae, and the intracellular 
glutathione level was decreased to approximately 
30% of the normal level following expression of 
RipAY in yeast.  Although active site mutants of 
GGCT activity were non-toxic, addition of 
glutathione did not reverse the toxicity suggesting 
that the toxicity might be a consequence of 
activity against other γ-glutamyl–compounds. 
Intriguingly, RipAY protein purified from a 
bacterial expression system did not exhibit any 
GGCT activity, whereas it exhibited robust GGCT 
activity upon its interaction with eukaryotic 
thioredoxins, which are important for intracellular 
redox homeostasis during bacterial infection in 
plants.  Our results suggest that RipAY has 
evolved to sense the host intracellular redox 
environment, which triggers its enzymatic activity 
to create a favorable environment for R. 
solanacearum-infection.  
 
Numerous bacterial pathogens of plants and 
animals inject virulence proteins, so-called 
effectors, directly into the host cell cytoplasm 
through specialized secretion apparatuses, such as 
the type III secretion system (T3SS).  The 
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translocated T3SS effector proteins manipulate 
diverse host cellular processes including 
cytoskeletal reorganization, signal transduction, 
gene expression, vesicular trafficking, autophagy 
and DNA replication to promote infection and 
ultimately cause disease (1,2).  Although the 
identification of the biochemical activities of these 
effector proteins is essential to understand the 
molecular mechanism of pathogenesis, it has been 
of great difficulty to predict the molecular 
functions based on their primary sequences 
because many effector proteins have limited 
similarity to known proteins and some effectors 
can be considered “convergently evolved” mimics 
of their eukaryotic cell counterparts (3).  
Furthermore, thanks to extensive genome 
sequencing programs, coupled with robust 
computational predictions of sequence motifs 
characteristic of effector proteins, the number of 
putative effectors identified in the genomes from 
many bacterial pathogens is continuously 
accumulating in the database (4).  For the above 
reasons, a function-based method to efficiently 
analyze effector proteins is desired.   Interestingly, 
effector proteins have been observed to confer a 
growth inhibition phenotype when 
heterologously-expressed in the yeast 
Saccharomyces cerevisiae (5,6).  This growth 
inhibition is thought to be the consequence of the 
effector-induced compromise of cellular processes 
conserved between yeast and higher eukaryotes.  
For example, Lesser and Miller (7) showed that 
the Yersinia effector YopE, which functions as 
Rho GTPase activating protein (RhoGAP), blocks 
actin polarization and cell cycle progression 
through its RhoGAP activity.   Importantly, 
growth inhibition is a genetically tractable 
phenotype, and it provides a variety of means to 
investigate modes of action of these effectors 
toward host cell targets. 
Ralstonia solanacearum, which is a widely 
distributed soil-borne phytopathogen, causes lethal 
bacterial wilt of more than 200 plant species, 
including economically important crops, such as 
tomato, potato, and tobacco (8).  Among the 
pathogenicity determinants of this bacterium, 
T3SS was shown to play an essential role in 
pathogenicity as the corresponding mutants were 
avirulent on host plants (9).  In general, compared 
to animal pathogens, bacterial plant pathogens 
such as Xanthomonas spp. or Pseudomonas 
syringae contain larger numbers (~30–40) of 
effectors, but the R. solanacearum effector 
repertoire is exceptionally large, probably due to 
its wide host range (10).  Post-genomic functional 
analyses using regulatory-based approaches and/or 
T3SS-translocon assays have identified the nearly 
complete repertoire of 70–75 effectors in the 
reference strain GMI1000 and the 
phylogenetically close strain RS1000 (11).  The 
investigation of the R. solanacearum strain 
complex (RSSC) pangenome also identified 
additional families of likely effector proteins with 
no homology to other previously identified 
effectors, and thus the current estimated number of 
effector families is approximately 110 among 11 
strains representative of the biodiversity of the 
RSSC (12).  Individual R. solanacearum strains 
typically possess around 60–75 effectors.  Effector 
repertoire comparison revealed a group of 32 core 
effectors present in 10 of 11 strains (13).  To date, 
only a few of R. solanacearum effectors have been 
assigned molecular functions and targets (14-16), 
but most of these effectors remain functionally 
uncharacterized.   
In this study, we screened R. solanacearum 
effectors using a yeast expression system and 
identified RipAY as an effector whose expression 
causes growth inhibition in yeast.  RipAY, which 
is one of the R. solanacearum core effectors, has 
previously been shown experimentally to be an 
effector injected into host plant cells via T3SS 
(17), but the molecular function of this effector 
has yet to be characterized.  Bioinformatics 
analysis revealed that RipAY contains a ChaC 
domain, which is a conserved domain found in all 
phyla examined, but whose molecular function 
was totally unknown when we started our study.  
Recently, it has been reported that yeast and 
mammalian ChaC-domain containing proteins 
exhibit γ-glutamyl cyclotransferase (GGCT) 
activity specifically to degrade glutathione (18).   
We demonstrated that RipAY exhibits robust 
GGCT activity and significantly decreases 
intracellular glutathione in yeast.  Surprisingly, we 
failed to detect GGCT activity of recombinant 
RipAY expressed in Escherichia coli.  However, 
we could detect robust GGCT activity when 
RipAY was activated by yeast or plant 
thioredoxins.  Both glutathione and thioredoxins 
are important for maintaining cellular redox 
homeostasis and also indispensable for proper 
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activation of plant innate immunity during 
pathogen infection (19,20).  Together, our data 
provide new insights that R. solanacearum 
perturbs the host redox environment to allow 
bacterial infection. 
 
EXPERIMENTAL PROCEDURES 
Strains, Plasmids and Media—Descriptions of the 
strains and plasmids used in this study are 
presented in Tables 1, 2, and 3.  Escherichia coli 
DB3.1 (Life Technologies) was used for the 
construction and amplification of the GatewayTM 
vectors, and E. coli DH5α or JM109 was the 
bacterial host for all the other plasmids 
constructed.  Coding sequences were amplified by 
PCR using KOD plus neo polymerase (Toyobo) or 
PrimeSTAR GXL polymerase (Takara Bio).  
Plasmids were sequenced to ensure that no 
mutations were introduced due to manipulations.  
Yeast transformation was performed using the 
lithium-acetate method (21).   Mutant constructs 
were generated by site-directed mutagenesis (22) 
and confirmed by sequencing.  The media used for 
yeast culture were synthetic dextrose (SD) 
medium (2% glucose, 0.67% yeast nitrogen base 
without amino acids) and synthetic galactose 
(SGal) medium (2% galactose, 0.67% yeast 
nitrogen base without amino acids).   Appropriate 
amino acids and bases were added to SD or SGal 
medium as necessary.   Yeast cells were cultured 
at 26°C unless otherwise stated.   
Phylogenetic Analysis—Phylogenetic trees of 
ChaC domain containing proteins including 
RipAY or thioredoxins from various organisms 
were created with MEGA6 (23).  The amino acid 
sequences of ChaC proteins or thioredoxins from 
NCBI database were aligned with CLUSTAL-W, 
from which a maximum-likelihood phylogenetic 
tree was created.  
Homology Modeling and Structure Analysis — The 
RipAY protein sequence was used for fold 
recognition using Phyre2 server 
(http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi
?id=index).  This search identified human GGCT 
(C7 orf24, PDB ID: 2PN7 and 2RBH) as best 
template.  We used the alignment provided by 
Phyre2 server to construct models for RipAY 
using CueMol molecular graphics software 
(http://www.cuemol.org/ja/).     
Production and Purification of Recombinant 
Proteins in E. coli—For the purification of the 
His6-tagged recombinant proteins, Rosetta-gami B 
(DE3) cells (EMD) carrying pET23d-GCG1, 
DUG1, RipAY, or TRX1 plasmid or 
pDEST17-TRXA or -TRX-h2, -h3, -h5 or 
TRX-h5C39, 42S plasmid were grown in 600 mL of 
Luria-Bertani (LB) medium with 34 µg/mL 
chloramphenicol, and 100 µg/mL ampicillin at 
37°C to an OD600 of 0.8.  The bacteria were then 
moved to 18°C for 30 min and the protein 
expression was induced by the addition of IPTG to 
0.3 mM for 6 h.  The cells were collected by 
centrifugation at 10,000 × g for 5 min.  The cell 
pellet was resuspended in 30 mL of binding buffer 
(50 mM NaH2PO4, 500 mM NaCl, 5 mM 
imidazole, pH 8.0) containing 1 mM PMSF and 
disrupted by sonication.  The lysate was cleared 
by centrifugation at 10,000 × g for 30 min at 4°C 
and the cleared lysate was applied to the HisTrap 
FF 1-mL column (GE healthcare) equilibrated 
with binding buffer.  The column was then washed 
with 20-column volume of binding buffer and 
eluted with elution buffer (50 mM NaH2PO4, 500 
mM NaCl, 300 mM imidazole, pH 8.0).  Fractions 
containing the recombinant His6-tagged fusion 
proteins were collected.  Purified His6-tagged 
thioredoxins were treated with 20 mM 
dithiothreitol (DTT) at RT for 15 min to reduce 
thioredoxins.  Purified proteins were subsequently 
dialyzed into PBS, and protein concentrations 
were determined using a micro BCA protein assay 
kit (Thermo Scientific). 
Measurement of Cys-Gly Peptidase 
(Dug1)-coupled GGCT Activity of His6-tagged 
RipAY and Gcg1 Purified from E. coli—GGCT 
activity toward glutathione as substrate was 
carried out using Dug1-coupled assay as 
previously described (18), with some 
modifications.  In brief, 0.4 µM Gcg1 or 0.04 µM 
RipAY with appropriate concentrations of the cell 
lysates from various organisms or thioredoxins 
purified from E. coli was incubated with 
glutathione for 20 min at 37°C in 50 µL of 
reaction mixture containing 50 mM Tris-HCl (pH 
8.0).  The reaction was terminated by addition of 
20 µL of 0.25 N HCl and then neutralized with 
addition of 8.4 µL of 1 M Tris and made up to 100 
µL with 50 mM Tris-HCl (pH 8.0).   Ten 
microliters of the reaction mixture was then 
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transferred to a new tube to which was added 2 µL 
of Dug1 reaction mixture; this converts the 
Cys-Gly dipeptide into free cysteine and glycine. 
The Dug1 reaction mixture consisted of 20 µM 
MnCl2 and 1 µg recombinant S. cerevisiae Dug1p, 
a Cys-Gly peptidase purified from E. coli.  This 
reaction mixture was further incubated for 1 h at 
37°C.  The free cysteine generated was measured 
by acidic ninhydrin solution (20 g ninhydrin 
dissolved in acetic acid and HCl that are mixed in 
a 3:2 ratio) were added to the reaction mixture and 
the reaction mixture incubated at 100°C for 10 
min to develop the pink color.  Two-hundred 
microliters of colored solutions was transferred to 
a 96-well plate and the OD was measured at 570 
nm using microplate reader (Bio-Rad).  The assay 
was performed in triplicates and data are mean ± 
SEM. 
Measurement of GGCT Activity of Protein 
A-tagged RipAY and Gcg1—GCG1, ripAYWT or 
ripAYE216Q genes on pDONR221 donor vector 
were cloned into the protein A-tagging gateway 
destination vectors, pMT1371 for E. coli or 
pMT1373 for S. cerevisiae by LR reaction.  E .coli 
Rosetta gami B (DE3) cells carrying 
pMT1371-GCG1, ripAYWT, ripAYE216Q or 
ripAYC333S  plasmids were cultured in 100 mL of 
LB medium containing 34 µg/mL 
chloramphenicol, and 100 µg/mL ampicillin at 
37°C to an OD600 of 0.8.  The bacteria were then 
moved to 18°C for 30 min and the protein 
expression was induced by the addition of IPTG to 
0.3 mM for 6 h.  E. coli cells expressing Protein 
A-tagged Gcg1, RipAYWT, RipAYE216Q or 
RipAYC333S proteins were suspended in IPP150 
buffer  (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 
50 mM EDTA) and disrupted by sonication to 
generate the E. coli lysates.  S. cerevisiae cells 
carrying pMT1373-GCG1, ripAYWT or ripAYE216Q 
plasmids were cultured in 20 mL of SD (-Ura) 
liquid medium at 26°C to an OD600 of 1.0 and then 
cells were washed twice with sterilized water and 
resuspended in 20 mL of SGal (-Ura) liquid 
medium and cultured at 26°C for 17 h to induce 
the protein expressions.   S. cerevisiae cells 
expressing Protein A-tagged Gcg1, RipAYWT or 
RipAYE216Q proteins were suspended in 500 µl of 
1 M sorbitol-50 mM EDTA solution containing 10 
mM DTT with 1 mg Zymolyase-20T (Nakarai 
Tesque Inc.) to obtain spheroplasts.  Spheroplasts 
were washed once with 1 M sorbitol-50 mM 
EDTA and resuspended with 1 mL of IPP150 
buffer containing 2 µM pepstatin A and 1 mM 
PMSF and homogenized with a dounce 
homogenizer (10 strokes) on ice to generate the S. 
cerevisiae lysates.  The lysates from E. coli or S. 
cerevisiae cells were cleared by centrifugation at 
10,000 × g for 30 min at 4°C and 50 µL of 
IgG-sepharose beads (50% v/v) were added into 
the cleared lysate and incubated for 2 h at 4°C on 
a rotating wheel.  The beads were washed three 
times with the same buffer.  The protein A-tagged 
fusion protein-immobilized beads were used for 
measuring the GGCT activity by a Dug1-coupled 
method as described above.  For activation of 
affinity-purified Protein A-tagged RipAY from E. 
coli, the protein A-tagged fusion 
protein-immobilized beads were incubated with 
the total protein lysate from yeast cells in 1 mL 
IPP150 buffer at 4°C for 2 h, washed three times 
with IPP150 buffer and then used for measuring 
the GGCT activity by a Dug1-coupled method as 
described above.   
Immunoblot Analysis—Yeast cells expressing 
GFP-tagged RipAY or other ChaC proteins were 
collected and resuspended in 1 mL of PBS.  After 
the addition of trichloroacetic acid (TCA) to a 
final concentration of 10%, cells were incubated 
on ice for 15 min and precipitated by 
centrifugation.  TCA-treated yeast cells were 
washed twice with 1 mL ice-cold acetone and 
dried.  Total proteins were extracted from the 
dried cells by beating cells with glass beads (5 min 
× 2 pulses with a 5-min interval at 65°C) in 
Urea-SDS cracking buffer (6 M urea, 1% SDS, 50 
mM Tris-HCl, pH 7.5).  The total protein 
concentration of the cell extracts was determined 
using a microBCA protein assay kit (Thermo 
Scientific).  Ten microgram aliquots of total 
protein were subjected to immunoblot analysis, 
which was performed using affinity-purified rabbit 
anti-GFP antiserum (our laboratory stock) or 
rabbit anti-G6PDH antibody (Sigma, A9521) and 
horseradish peroxidase-conjugated anti-rabbit IgG 
serum (Cell signaling technologies).  Signals were 
detected using Immunostar LD western blotting 
detection reagent (Wako). 
Measurement of Total Cellular Glutathione—Ten 
OD600 of yeast cells expressing RipAY and their 
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mutants under the control of the GAL1 promoter 
were washed once with 1 mL of KPE (0.1 M 
potassium phosphate buffer with 5 mM EDTA, pH 
7.5) and lysed in 200 µL of 5% sulfosalicylic acid 
using glass beads.  Cells were vortexed for 1 min 
with 1 min intervals for 10 times and centrifuged 
for 10 min at 4°C.  Total cellular glutathione in 
yeast was measured as previously described (24).  
In brief, 10 µL of supernatant was mixed with 60 
µL of DTNB (2 mg/3 mL) and 60 µl of 
glutathione reductase (2.5 units/mL) in 96-well 
plate.  Sixty microliters of NADPH (2 mg/3 mL) 
was added in the above mixtures to start the 
reaction.  Absorbance was measured at every 15 s 
at 415 nm.  Absorbance at 2 min was used to 
compare the glutathione level in the different 
samples.  Total cellular glutathione in yeast is 
normalized to OD600 of yeast cells. 
Measurement of Total Cellular Glutathione in 
Bacteria-inoculated Plants—A 108 CFU/mL 
suspension of R. solanacearum OE1-1 (wild-type, 
WT) (25), RK5081 (T3SS mutant, ∆hrcU-1) or 
RK7101 (∆ripAY-4) in an approximately 50 µL 
volume was inoculated into fully expanded leaves 
of 6-8 week old susceptible eggplant (Solanum 
melongena cv. Senryo 2-gou) using a needleless 
disposable syringe, and the bacteria-inoculated 
plants were maintained in a greenhouse facility.  
Two leaf disks (0.8 cm2 each) were taken 1 day 
after inoculation, and frozen in liquid nitrogen.  
The frozen samples were extracted by shaking five 
times with 5-mm diameter stainless beads for 30 s 
in a 2.0-mL screw-capped vial using a bead-beater 
device.  Three-hundred microliters of 5% 
sulfosalicylic acid in KPE was added to the 
samples and then the samples were vortexed and 
centrifuged at 8,000 × g for 20 min at 4°C.  Total 
cellular glutathione of the samples extracted from 
bacteria-inoculated plants was measured by the 
same method as that of the samples from yeast as 
described above.  Total cellular glutathione in 
bacteria-inoculated leaf was normalized to mg of 
leaf material. 
Fluorescent Microscopic Analysis—Fluorescence 
of GFP in the non-fixed yeast cells was observed 
using an Olympus BX51 microscope (Olympus) 
with a GFP filter.  Images were captured with a 
Hamamatsu C11440-10C Orca-Flash 2.8 CMOS 
camera (Hamamatsu Photonics) using Metamorph 
software (Molecular Device).   
Yeast Two-Hybrid Analysis—The yeast two-hybrid 
(Y2H) analysis was performed using a 
GAL4-based yeast two-hybrid system according to 
manufacturer’s instruction (MATCHMAKER 
Two-Hybrid System 3; Clontech).  RipAY with 
E216Q active site mutation, RipAYE216Q was used 
for Y2H analysis to avoid the growth inhibition 
caused by its expression in yeast.  The ripAYE216Q 
gene was amplified by PCR and cloned into the 
EcoRI and BamHI sites of pGBKT7 vector to 
generate a construct of RipAYE216Q fused in-frame 
to the Gal4 DNA-binding domain (BD) as the bait.  
GatewayTM technology (Life Technologies) was 
used to construct the prey plasmids.  Thioredoxin 
cDNAs (R. solanacearum TrxA/RSc1188, S. 
cerevisiae Trx1, Arabidopsis thaliana Trx-h2, 
Trx-h3, and Trx-h5) were amplified by PCR and 
cloned into the gateway donor vector pDONR221 
by the BP reaction.  The pDONR221-Trx-h5 
plasmid was used to introduce the C39, 42S active 
site mutation into Trx-h5.  The thioredoxin genes 
on pDONR221 plasmid were cloned into 
pACT2-based gateway Gal4 activation domain 
(AD) plasmid, pMT731 by the LR reaction to 
generate the prey plasmids.  The bait and prey 
plasmids were cotransformed into a two-hybrid 
reporter yeast strain AH109 cells.  The 
transformants were spotted on SD (-Trp, -Leu) 
plates and SD plates with different stringency 
conditions (low: -Trp, -Leu, -His, medium: -Trp, 
-Leu, -His, + 1mM 3-AT and high: -Trp, -Leu, 
-His, -Ade) and the interaction of RipAY and 
thioredoxins was assessed by their growth under 
the different stringency conditions.   
Purification of the RipAY-Activator from 
Yeast—Soluble proteins were extracted from 10 g 
of S. cerevisiae MTY654 (dug3∆ ecm38∆ gcg1∆) 
cells mechanically disrupted by French Press.  The 
extracted S. cerevisiae proteins were precipitated 
with 100% ammonium sulfate.  Precipitated 
proteins were dialyzed overnight at 4°C against 6 
L of 20 mM Tris-HCl, pH 7.5.  S. cerevisiae 
proteins were separated over a HiPrep DEAE FF 
16/10 ion exchange column with a salt gradient 
from 0 M to 1 M NaCl (GE Healthcare).  
Individual fractions were assayed for their ability 
to stimulate GGCT activity of a recombinant 
RipAY purified from E. coli.  Fractions possessing 
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the majority of activity were pooled and dialyzed 
overnight at 4°C against 2 L of 20 mM Tris-HCl, 
pH 7.5, 1.5 M (NH4)2SO4.   After dialysis, S. 
cerevisiae proteins were separated on a HiPrep 
Butyl FF 16/10 hydrophobic interaction column 
with a salt gradient from 1.5 M to 0 M (NH4)2SO4 
(GE Healthcare).   Individual fractions retaining 
the activity were pooled, concentrated to 1 mL 
using an Amicon Ultra-2mL 3K centrifugal filter 
device (Millipore).  Positive fractions were then 
separated over a HiPrep 16/60 Sephacryl 200 high 
resolution gel filtration column (GE Healthcare).  
Proteins in this final purification step contained in 
the positive fraction were separated by Tricine 
SDS-PAGE and visualized with a Sil-Best Stain 
One (Nakarai Tesque Inc.) or a Coomassie 
brilliant blue (CBB) stain.   
In-gel digestion and following LC-MS/MS 
analysis of the activator protein from yeast was 
performed as described previously (26).  Protein 
identification was performed in the Agilent 
Spectrum MILL MS proteomics workbench 
against the Swiss-Prot protein database search 
engine (http://kr.expasy.org/sprot/). 
Statistical Analysis—Statistical analysis was 
performed using Graphpad Prism 6 or Microsoft 
Excel software, and specific tests noted in the text 
and figure legends. 
 
RESULTS 
Expression of a ChaC domain-containing effector, 
RipAY causes growth inhibition to yeast—To 
understand the molecular mechanism of 
pathogenesis for Ralstonia solanacearum, we 
screened the collection of 36 previously identified 
effector proteins of R. solanacearum GMI1000 
(13,27) using yeast galactose inducible-expression 
system.  This yeast expression screen revealed 8 
effectors that cause growth inhibition to yeast 
Saccharomyces cerevisiae.  Details of this screen 
along with the complete set of identified effectors 
will be described elsewhere (Hasegawa et al., in 
preparation).   
To predict the molecular function of 
identified effectors, we first searched for the 
functional domain or motif using the Pfam search 
engine (http://pfam.xfam.org/search) based on 
their primary sequences.  One of the identified 
effectors, RipAY (locus tag RSp1022) contains a 
ChaC domain, originally identified in a protein 
encoded by Escherichia coli chaC, and assumed to 
be a possible regulator of the cha operon (Ca++/H+ 
antiporter) (28).  Orthologues of the ChaC protein 
are found in all phyla examined.  We investigated 
the phylogenic relationship of the protein with 
other ChaC protein sequences from various 
organisms.  RipAY and Aave_4606 identified in 
the genome of the cucurbit pathogenic bacterium 
Acidovorax citrulli (referred to as the class II 
ChaC protein family) are clearly an out-group of 
the ChaC proteins conserved in various organisms 
(referred to as the class I ChaC protein family) in a 
phylogenic reconstruction (Fig. 1A).  Interestingly, 
both R. solanacearum and A. citrulli genome 
contain another ChaC protein, RSc0782 and 
Aave_2801 respectively, which belong to the class 
I ChaC protein family.  RipAY and Aave_4606 
have N- and C-terminal extension sequences 
outside of their ChaC domains and are much 
larger than the class I ChaC proteins (~400 a.a. for 
class II vs ~200 a.a. for class I) (Fig. 1B).  The 
ChaC domain of RipAY shows lower identity to 
that of the class I ChaC proteins (6.2~21.3%), but 
higher identity to that of the class II ChaC protein, 
Aave_4606 (46.4%) (Fig. 1B).  It seems that 
RipAY and Aave_4606 most probably originated 
from a duplication of the class I ChaC protein 
family genes and evolved to acquire a specific 
function as an effector.   
We next examined whether heterologous 
expression of the other ChaC proteins also caused 
growth inhibition to yeast as observed in that of 
RipAY (Fig. 1C).   Expression of neither GFP 
alone nor the GFP-tagged C-terminus of other 
ChaC proteins, showed any impact on yeast 
growth (Fig. 1C); nonetheless the protein 
expression level, except for RSc0782 and 
Aave_4606, was even higher than that of RipAY 
in yeast (Fig. 1D).  We failed to detect the 
expression of the Aave_4606-GFP fusion protein 
in yeast, probably because the Aave_4606 gene 
has a high GC content (73%) and many rare 
codons for yeast [34 rare codons (CGC or CGG) 
out of 38 total codons for arginine] (data not 
shown).  We also examined the localization of the 
proteins in yeast cells using the native 
fluorescence of GFP fused at their C-termini and 
found GFP fluorescence of RipAY and most of the 
other ChaC proteins expressed in the cytoplasm of 
yeast cells (Fig. 1E and Fujiwara and Tabuchi, 
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unpublished result).  These results suggest that 
RipAY affects the cytoplasmic component(s) with 
different activities from the other ChaC proteins.  
 Expression of RipAY in yeast causes a decrease in 
intracellular glutathione via its GGCT 
activity—Recently, it has been reported that the 
class I ChaC proteins from yeast, plants, and 
mammals function as γ-glutamyl cyclotransferases 
(GGCT) acting specifically to degrade glutathione 
but not other γ-glutamyl peptides (Fig. 2A) (18,29).   
The ChaC domain of RipAY has limited similarity 
to that of the class I ChaC proteins (Fig. 1B).  
However, the structure of RipAY modeled on the 
Phyre2 website 
(http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi
?id=index) indicated that it closely resembles the 
structure of human GGCT (C7orf24) (30) (Fig. 2, 
B and C).  There is a very high structural similarity 
between RipAY and GGCT, although there is little 
amino acid similarity (data not shown).  The 
Phyre2 search showed that most key residues in 
the catalytic domain of GGCT aligned with 
corresponding residues of RipAY (Fig. 2C).  
Furthermore, multiple sequence alignment of the 
ChaC proteins from various organisms revealed 
that RipAY contains the signature motifs for the 
substrate binding site (Y129xSL) and catalytic 
glutamate residue (E216) (Fig. 2D), indicating that 
it may function in a similar manner.   
To ask directly whether RipAY had GGCT 
activity toward glutathione, we first determined 
the GGCT activity of RipAY expressed in yeast.   
In this regard, we employed a protein A-tag to 
affinity-purify the proteins using IgG-beads 
directly from the Protein A-tagged 
RipAY-expressing yeast lysates and then 
determined GGCT activity of the beads bound 
with RipAY protein using a Dug1-coupled assay 
for ChaC family proteins (18).  To prevent 
contamination of endogenous glutathione 
degrading enzymes from the yeast lysate, we used 
a glutathione degrading enzyme deficient strain 
(dug3∆ ecm38∆ gcg1∆ triple mutant) to express 
the protein A-tagged ChaC proteins in yeast cells.  
Consistent with a previous report (18), the beads 
bound with yeast class I ChaC-family protein 
Gcg1 showed significant GGCT activity (Fig. 2E).  
Remarkably, we detected robust GGCT activity in 
the beads bound with wild-type RipAY 
(RipAYWT), but not with the catalytically inactive 
mutant RipAY (RipAYE216Q).  Interestingly, 
RipAYWT showed approximately 4.5 times higher 
activity than that of the beads bound with Gcg1, 
even though the amount of the RipAYWT protein 
was much lower than that of Gcg1 (Fig. 2F).  This 
result demonstrated that RipAY protein purified 
from yeast possesses GGCT activity toward 
glutathione in vitro. 
To ask whether yeast growth inhibition was 
caused by the GGCT activity of RipAY, we next 
performed a mutational analysis of the putative 
catalytic residues in the ChaC domain of RipAY 
and then assessed the mutants using the yeast 
growth inhibition test (Fig. 2G).  Substitution of 
the putative catalytic glutamate residue to 
glutamine (E216Q) or the conserved 
substrate-binding site to alanine (Y219A, S131A, 
L132A) almost completely restored the yeast 
growth inhibition caused by expression of RipAY.  
However, the substitution of non-conserved 
leucine at position 130 (L130) to alanine (L130A) 
resulted in only weak restoration.  Furthermore, 
the mutation of L130 to glycine, L130G, which 
mimics the substrate-binding site of the class I 
ChaC-protein, could partially restore the growth, 
indicating that RipAY may have a different 
substrate binding mechanism from that of the class 
I ChaC proteins.  Immunoblots were probed with 
anti-GFP (for RipAYs) and anti-G6PDH (as an 
internal control) antibodies revealing similar 
amounts of RipAY-GFP proteins (Fig. 2H).   
We next examined whether expression of 
RipAY proteins affected the intracellular 
glutathione level in yeast (Fig. 2I).  Cells 
over-expressing Gcg1 showed a modest decrease 
in glutathione (decreased to 69% relative to the 
control).  Interestingly, cells expressing RipAYWT 
led to a marked decrease in glutathione (decreased 
to 29% relative to the control), whereas cells 
expressing RipAYE216Q did not show significant 
glutathione decrease.  Together, these data showed 
that RipAY functions as a GGCT both in vitro and 
in vivo. 
Addition of exogenous glutathione did not restore 
the RipAY-dependent growth inhibition in 
yeast—We next investigated the effect of addition 
of exogenous glutathione on growth of 
RipAY-expressing yeast cells.  Unexpectedly, the 
addition of exogenous glutathione could not 
restore the RipAY-dependent growth inhibition in 
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both yeast WT and gsh1∆ mutant, which has a 
defect in endogenous glutathione synthesis (Fig. 
3A).  Interestingly, expression of the conserved 
substrate-binding site mutant (Y129A), whose 
expression does not cause growth inhibition in 
WT cells, causes growth inhibition in gsh1∆ 
mutant cells on medium containing 1 µM 
glutathione, but an excess of glutathione (100 µM) 
could restore this growth inhibition.  Based on this 
result, we hypothesized that kinetics of glutathione 
degradation by RipAY is much faster than that of 
glutathione uptake by plasma membrane 
glutathione transporter, Hgt1 (31).  As a 
consequence, available glutathione is limited in 
yeast cells expressing RipAY, causing growth 
inhibition.  To confirm this hypothesis, we 
investigated the effect of over-expression of Hgt1 
in yeast cells expressing RipAY.  Over-expression 
of Hgt1 using the strong constitutive TEF1 
promoter conferred a glutathione sensitive 
phenotype to yeast WT cells (Fig. 3B) as 
previously reported (32) and showed an increased 
intracellular glutathione level (426 ± 39% for the 
30 min-culture with glutathione and 249 ± 23% 
for the 19 h-culture with glutathione relative to 
that of control cells) when cells were cultured in 
medium containing 100 µM glutathione (Fig. 3, C 
and D).  Surprisingly, we observed that 
over-expression of Hgt1 could not restore the 
RipAY-dependent growth inhibition on medium 
containing 100 µM glutathione (Fig. 3B), even 
though the intracellular glutathione level was 
restored (181± 10% for the 30 min-culture with 
glutathione and 91 ± 15% for the 19 h-culture with 
glutathione relative to that of control cells) in 
these conditions (Fig. 3, C and D).  Collectively, 
these results indicate that RipAY has another 
target(s) besides glutathione at least in yeast.  
Inoculation of R. solanacearum into eggplant 
leaves causes a decrease in intracellular 
glutathione—To explore the function of RipAY in 
host plant cells during R. solanacearum infection, 
we performed an inoculation test of R. 
solanacearum WT and ripAY-deficient (∆ripAY) 
cells into eggplant leaf mesophyll tissues.  We 
observed typical necrotic lesions in the area 
inoculated with both R. solanacearum WT and 
∆ripAY cells at 2 days post-inoculation, but not in 
the area inoculated with a type III secretion system 
(T3SS) mutant, ∆hrcU and control mock (Fig. 4A), 
indicating that RipAY is dispensable for virulence 
of R. solanacearum on eggplant.   
We next examined glutathione levels in 
eggplant leaves inoculated with R. solanacearum.  
Lysates were extracted from the area inoculated 
with R. solanacearum WT, ∆ripAY, and ∆hrcU 
cells and control mock at 1 day post-inoculation, 
and then total glutathione level of these lysates 
was analyzed (Fig. 4B).  We observed a modest 
decrease of glutathione in ∆hrcU-inoculated 
eggplant leaves (decreased to 79% relative to the 
control), indicating pathogen associated molecular 
pattern (PAMP)-triggered immunity 
(PTI)-response may affect the host glutathione 
homeostasis.  Strikingly, eggplant leaves 
inoculated with R. solanacearum WT showed a 
significant decrease in glutathione (decreased to 
40% relative to the control), whereas eggplant 
leaves inoculated with ∆ripAY did not show any 
significant decrease (Fig. 4B), implying that 
RipAY functions as a GGCT in host plant cells 
during R. solanacearum-infection.    
RipAY GGCT activity is triggered by a eukaryotic 
factor—To perform a detailed enzyme kinetic 
analysis of GGCT activity of RipAY toward 
glutathione, recombinant RipAY and Gcg1 
proteins were purified from E. coli using His6-tag 
and Ni-NTA affinity chromatography (Fig. 5A) 
and their GGCT activity was determined by 
Dug1-coupled assay (18).  As shown in Fig. 5B, 
the recombinant Gcg1 protein showed significant 
GGCT activity toward glutathione as previously 
described (18).  However, we failed to detect 
GGCT activity of recombinant RipAY, although 
we could detect robust GGCT activity in RipAY 
expressed in yeast (Fig. 2C).  Based on these 
results, we hypothesized that RipAY might 
acquire its GGCT activity from an activator 
harbored in yeast cells, but not in E. coli cells.  To 
test this hypothesis, the beads bound with 
recombinant protein A-tagged RipAYWT- or 
RipAYE216Q proteins expressed in E. coli were 
preincubated with a yeast extract and then GGCT 
activity of the beads was measured.  As shown in 
Fig. 5C, yeast extract could stimulate the GGCT 
activity of RipAYWT, but not that of catalytically 
inactive RipAYE216Q in a dose-dependent manner, 
showing that yeast extract contains the activator(s) 
for RipAY.  We did not observe any size changes 
in RipAY proteins after treatment with yeast 
 at U
A
B/FA
C. M
ED
ICIN
A
 on February 1, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
γ-Glutamyl cyclotransferase activated by eukaryotic thioredoxins
 
extract (Fig. 5D), indicating that activation of 
RipAY is not dependent on cleavage or 
modification of the protein.  Furthermore, not only 
a yeast extract, but also other eukaryotic cell 
extracts including those of human cultured cells 
(HeLa), and two plants, Arabidopsis (Arabidopsis 
thaliana) and eggplant (Solanum melongena), but 
not that of R. solanacearum, could stimulate 
GGCT activity of a bacterially expressed 
RipAY-His6 protein (Fig. 5E).  These data 
demonstrated that RipAY acquires its GGCT 
activity by a eukaryote-specific factor.    
Purification and identification of the activator for 
RipAY from yeast extract—Heat treatment (95°C 
for 5 min) or extensive dialysis of the yeast extract 
did not eliminate the activation of RipAY, but 
proteinase K treatment completely eliminated, 
suggesting that the activator must be heat-stable 
and proteinaceous (data not shown).  To identify 
the activator of RipAY from a yeast extract, a 
biochemical approach was employed.  Proteins 
extracted from yeast cells were sequentially 
fractionated by anion exchange, hydrophobic 
interaction, and gel-filtration chromatography (Fig. 
6A).  Fractions were assayed for their ability to 
stimulate GGCT activity of RipAY.  Those 
GGCT-stimulation activities from the final 
purification step were analyzed by Tricine 
SDS-polyacrylamide gel electrophoresis (Tricine 
SDS-PAGE) (Fig. 6B).  A single 11-kDa protein 
was correlated with activity (Fractions #37-41).  
Mass spectrometry identified this protein as Trx1 
and Trx2 proteins, isoenzymes of yeast 
cytoplasmic thioredoxin (Trx) (Fig. 6C).   
Yeast thioredoxins can stimulate GGCT activity of 
RipAY both in vivo and in vitro—The yeast 
proteome contains three Trx isoenzymes: two 
cytoplasmic isoenzymes, Trx1 and Trx2, and one 
mitochondrial isoenzyme, Trx3.  Because RipAY 
is expressed in the cytoplasm in yeast cells (Fig. 
1E), we expected that the growth inhibition effect 
caused by RipAY must be eliminated by 
simultaneous deletion of its candidate activators, 
Trx1 and Trx2.   RipAY and Gcg1 proteins were 
expressed under the control of doxycycline 
repressible Tet-Off promoter (33) in yeast WT, 
trx3∆ single-, trx1/2∆ double- and trx1/2/3∆ 
triple-mutant cells and the growth of yeast was 
scored by spot assay (Fig. 7A).  Interestingly, we 
observed that over-expression of Gcg1 also causes 
growth inhibition in both trx1/2∆ and trx1/2/3∆ 
mutants (Fig. 7A, lower panels), suggesting that a 
subtle decrease of glutathione in Trx-deficient 
cells causes growth inhibition because Trx system 
shares some redundant functions in cellular redox 
homeostasis with the glutathione system (34).  
Contrary to our expectation, we still observed the 
growth inhibitory effect by expression of RipAY 
in trx1/2∆ mutant cells (Fig. 7A, lower middle 
panel).  However, an additional deletion of TRX3 
from trx1/2∆ mutant (trx1/2/3Δ) clearly restores 
the growth inhibition (Fig. 7A, lower right panel).  
Consistent with these results, lysate from 
trx1/2/3∆ cells almost completely lost the 
activation activity of RipAY, whereas lysate from 
trx1/2∆ cells still retained weak, but significant 
activation activity (Fig. 7B).  In addition, the 
lysate from trx3Δ cells could activate GGCT 
activity of RipAY and also trx3Δ cells expressing 
RipAY exhibits growth inhibition.  These data 
indicate that major activator for RipAY in yeast 
cell must be Trx1 and Trx2.  Finally, we 
demonstrated that a bacterially expressed 
Trx1-His6 protein could stimulate GGCT activity 
of RipAY in vitro (Fig. 7C).  Taken together, these 
results demonstrated that yeast Trxs could 
stimulate GGCT activity of RipAY both in vivo 
and in vitro.   
Plant Trxs bind to and activate RipAY in an 
isoform-specific manner—Next, we investigated 
whether plant Trxs could also activate RipAY.  
Since Arabidopsis extract could activate RipAY in 
vitro (Fig. 5E) and Trxs from Arabidopsis are 
relatively well characterized, we employed the 
Arabidopsis Trxs for this purpose.  The 
Arabidopsis genome encodes 19 Trxs belonging to 
six major groups, f, m, h, o, x and y (35).  
Whereas most of these Trxs are located in 
chloroplasts and mitochondria, the h-type Trxs, 
which consist of eight isoenzymes, are generally 
thought to be located in the cytoplasm.  Among 
these h-type Trxs in Arabidopsis, AtTrx-h2 has 
highest similarity to yeast Trxs (Fig. 8F).  
Furthermore, AtTrx-h3 is the most highly 
constitutively expressed cytoplasmic Trx, and 
AtTrx-h5 is substantially up-regulated upon 
infection with Pseudomonas syringae (36).  We 
therefore chose these three Arabidopsis Trxs as 
candidate activators for RipAY.  We first tested 
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whether RipAY directly interacted with Trxs using 
yeast two-hybrid (Y2H) analysis.  As shown in 
Fig. 8A, we could detect the interaction of RipAY 
with all eukaryotic Trxs tested, but not with R. 
solanacearum Trx, RsTrxA under both low and 
medium stringency conditions (–Trp/-Leu/-His 
and –Trp/-Leu/-His/+3AT, respectively).  
However, we could detect the interaction of 
RipAY with only AtTrx-h5 under high stringency 
conditions (–Trp/-Leu/-His/-Ade), indicating that 
RipAY binds AtTrx-h5 with higher affinity than 
the other eukaryotic Trxs in Y2H.  Trxs catalyze 
disulfide reduction through a redox-active site 
WCxPC (34).  We also examined whether redox 
active disulfide residues of AtTrx-h5 are required 
for the binding to RipAY.  The redox-inactive 
mutant AtTrx-h5CS, in which active site cysteine 
residues at position 39 and 42 were substituted by 
serine, showed decreased binding and 
activation-activity relative to the WT, but still 
bound to RipAY and exhibited significant 
activation activity (Fig. 8, A and E).  Moreover, 
the RipAYCS mutant, in which the sole cysteine 
residue at position 333 was substituted by serine, 
also bound to both the WT and the redox-inactive 
mutant of AtTrx-h5.  Furthermore, heterologous 
expression of the RipAYCS mutant caused growth 
inhibition of yeast (Fig. 8B) and recombinant 
RipAYCS mutant protein expressed in E. coli 
exhibited Trx-dependent activation in vitro, which 
was similar to that of RipAYWT (Fig. 8, C and D).  
Taken together, these data indicate that the 
eukaryotic Trxs bind to RipAY without 
intermolecular disulfide bound-dependent 
covalent interaction.   
We next tested if the plant Trxs stimulated 
GGCT activity of RipAY in vitro.  The GGCT 
activity of RipAY toward glutathione was 
measured in the presence of various 
concentrations of each recombinant Trx 
isoenzyme.  As shown in Fig. 8E, AtTrx-h5 could 
most effectively stimulate GGCT activity of 
RipAY (more than 10-fold compared to AtTrx-h2: 
0.790 ± 0.073 µM/sec, at 5 µM AtTrx-h5 vs 0.066 
± 0.009 µM/sec, at 5 µM AtTrx-h2).  Interestingly, 
the RipAY-activation activity of Trxs was 
correlated with the RipAY-binding ability of Trxs 
(Order of RipAY-activation activity: AtTrx-h5 > 
AtTrx-h3 > ScTrx1 >> AtTrx-h2 ≥ AtTrx-h5CS).  
Addition of RsTrxA to RipAY failed to stimulate 
GGCT activity, consistent with its inability to bind 
RipAY.  Taken together, these data showed that 
plant Trxs bind to RipAY and stimulate its GGCT 
activity in an isoform-specific manner.  
Since heterologous expression of RipAY, but 
not the other ChaC proteins, caused growth 
inhibition to yeast (Fig. 1C) and a marked 
decrease of intracellular glutathione in yeast cells 
(Fig. 2F), we speculated that the catalytic 
efficiency of RipAY might be much higher than 
that of the class I ChaC proteins.  To confirm this 
speculation, we performed kinetic analysis of 
RipAY and Gcg1 toward glutathione and 
compared their kinetic parameters.  Both RipAY, 
which was activated by 8 µM AtTrx-h5, and Gcg1 
showed Michaelis-Menten kinetics toward 
glutathione (Fig. 9, A and B).  We observed some 
inhibition at high substrate (glutathione) 
concentrations.  The kinetic parameters revealed 
similar KM values for both Gcg1 (1.23 ± 0.17 mM) 
and RipAY (2.11 ± 0.17 mM), although the kcat 
values were markedly different, the kcat value of 
RipAY was 160-fold higher than that of Gcg1 
(52.8 ± 9.58 S-1 for RipAY vs 0.33 ± 0.02 S-1 for 
Gcg1) (Table 1).  Furthermore, the specificity 
constant, kcat/KM value of RipAY is 94-fold higher 
than that of Gcg1 (25.2 ± 1.22 S-1/mM for RipAY 
vs 0.27 ± 0.03 S-1/mM for Gcg1).  Collectively, 
we clearly demonstrated that the catalytic 
efficiency of RipAY is much higher than that of 
the class I ChaC protein. 
 
DISCUSSION 
The T3SS effector proteins exhibit various 
molecular activities that generally allow bacteria 
to escape from host immune systems and break 
down barriers for pathogen growth and 
dissemination.  Uncovering the molecular 
functions of T3SS effector proteins is therefore 
one of the most important subjects for a 
mechanistic understanding of pathogenesis (4).  In 
this study, we revealed that a ChaC domain 
containing effector protein RipAY from the plant 
pathogenic bacterium R. solanacearum modulates 
the abundance of host intracellular glutathione by 
acting as a eukaryotic thioredoxin-dependent 
GGCT.   
Expression of RipAY causes growth inhibition in 
yeast—We initially identified RipAY as one of the 
R. solanacearum effectors whose expression 
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causes growth inhibition in yeast (Fig. 1C).  
Subsequent analysis revealed that this growth 
inhibition effect might be caused by a decrease in 
glutathione, which is dependent on a ChaC 
domain in RipAY (Fig. 2E and F).  Kumar et al. 
(18) reported that expression of human Chac1 in 
yeast mutant cells with limited glutathione 
availability leads to apoptosis through depletion of 
intracellular glutathione and this effect is rescued 
by the addition of exogenous glutathione.  
Unexpectedly, we found that the addition of 
exogenous glutathione failed to rescue the growth 
inhibition caused by expression of RipAY (Fig. 
3A).  Furthermore, over-expression of Hgt1 in 
RipAY-expressing cells could not restore the 
growth inhibition on media containing glutathione, 
even though intracellular glutathione level was 
almost restored in this condition (Fig. 3, B and C).  
Importantly, since mutation in the putative 
catalytic site completely restored the growth 
inhibition, this effect is dependent on GGCT 
activity of RipAY (Fig. 3B).  These data clearly 
indicate that yeast growth inhibition must be a 
consequence of RipAY-dependent degradation of 
another yet unidentified γ-glutamyl compound(s) 
rather than glutathione.  Recently, Chi et al. (37) 
reported that mouse Chac1/Botch, which promotes 
embryonic neurogenesis through inhibition of 
Notch signaling, deglycinates the 
γ-glutamyl-glycine at position 1,669 of Notch to 
prevent the S1 furin-like cleavage of Notch.  
Further analysis will be required for understanding 
the molecular mechanisms underlying the yeast 
growth inhibition observed in the expression of 
RipAY. 
RipAY is a novel type of effector that targets host 
glutathione—To our knowledge, RipAY is the 
first T3SS effector targeting host intracellular 
glutathione.  Glutathione has been repeatedly 
reported to play a crucial role in plant immune 
responses during biotic stresses (20).  For instance, 
the Arabidopsis pad2-1 mutant, which was 
originally identified as a phytoalexin 
camalexin-deficient mutant, was shown to be 
mutated in γ-glutamycysteine synthetase (Gsh1), a 
critical enzyme that catalyzes the first committed 
step in glutathione synthesis (38).  Mutant pad2-1 
plants fail to accumulate significant levels of 
glutathione and are rendered highly susceptible to 
biotrophic pathogens and insects (19).  Oppositely, 
enhanced level of glutathione by expression of 
GSH1 in tobacco (Nicotiana tabacum) confers 
biotic stress tolerance, probably thorough the 
disease resistance-priming gene, NPR1-depedent 
salicylic acid (SA)-mediated pathway (39).  
Furthermore, Arabidopsis knockout mutants for 
one of two glutathione reductase genes, GR1, 
which show a constitutive increase in oxidized 
glutathione, accumulate less plant defense 
hormone, SA than the WT and show increased 
sensitivity to virulent P. syringae (40).  We show 
that inoculation of R. solanacearum WT into 
eggplant leaves causes a significant decrease of 
glutathione and mutation of RipAY in R. 
solanacearum restores this glutathione decrease 
(Fig. 3B).  Taken together, these results indicate 
that RipAY affects the host immune response by  
decreasing host intracellular glutathione.  
However, despite the importance of RipAY for 
host glutathione homeostasis, an R. solanacearum 
mutant lacking RipAY was not attenuated for 
virulence toward eggplant (Fig. 4A), arguing for 
the existence of additional effector proteins that 
interfere with a host disease-resistant signaling 
pathway.  Indeed, a systematical effector knockout 
approach for R. solanacearum failed to identify 
mutants with reduced pathogenicity on two host 
plants, indicating a functional overlap among 
effectors (41).     
Regulation of the abundance of host intracellular 
glutathione by RipAY—Given that most bacterial 
pathogens translocate only trace amounts of their 
effector proteins into host cell cytoplasm (42), it 
seemed that RipAY must be a GGCT with 
extremely high catalytic efficiency to decrease 
host intracellular glutathione during R. 
solanacearum-infection.  In fact, our enzyme 
kinetic analysis revealed that the kcat value of 
Trx-h5-activated RipAY was much higher than 
that of a S. cerevisiae class I ChaC-protein, Gcg1 
(160-fold), although both activated RipAY and 
Gcg1 shows similar KM value (Table 1).  Recently, 
Kumar et al. (29) reported a detailed enzyme 
kinetic analysis of Arabidopsis ChaC orthologues, 
AtGGCT2;2 and AtGGCT2;3.  Based on their data, 
we estimated that the kcat/KM value of RipAY is 
66.7- and 1081-fold higher than that of 
AtGGCT2;2 and AtGGCT2;3, respectively (Table 
1).  This extremely high catalytic efficiency of 
thioredoxin-activated RipAY compared to the 
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intrinsic class I ChaC proteins is logical, as 
probably very limited amounts of the bacterial 
effector are efficiently translocated inside the plant 
host cells.  Injection of a very active RipAY could 
allow depletion of the host intracellular 
glutathione during R. solanacearum-infection. 
Activation of RipAY by eukaryotic 
thioredoxins—A truly unexpected finding was that 
for RipAY to exhibit GGCT activity, it has to be 
bound and activated by host plant cytoplasmic 
thioredoxins in an isoform-specific manner (Fig. 
8E).  Recent findings provide remarkable 
examples for the emerging concept for 
spatiotemporal regulation of pathogen effectors by 
coupling the catalytic activity to the arrival into a 
host cells cytoplasm (42-46).  The mechanism of 
activation coupled with T3SS-dependent delivery 
ensures that eukaryotic cells are specifically and 
potently targeted and that the bacterium is 
protected from the toxic effects of its own 
enzymatic activity (46).  Interestingly, the GGCT 
activity of RipAY is stimulated by thioredoxins, 
which are relatively well conserved within both 
prokaryotes and eukaryotes and the R. 
solanacearum genome also contains five 
thioredoxin or thioredoxin-like proteins.  Our data 
suggest that eukaryotic, but not prokaryotic 
thioredoxin(s) can specifically bind to RipAY and 
stimulate GGCT activity of RipAY (Fig. 8, A and 
E).  Phylogenic tree analysis revealed that 
eukaryotic-type thioredoxins are clearly divided 
from prokaryotic-type thioredoxins (Fig.8F).  As 
one might expect, our results raise two interesting 
questions regarding how RipAY recognizes 
eukaryotic thioredoxins in an isoform-specific 
manner and how thioredoxins stimulate the GGCT 
activity of RipAY.  Further studies will be 
required for a better understanding of the 
mechanisms underlying thioredoxin-recognition 
and the enzyme activation of RipAY at the 
molecular level. 
A working model for the role of RipAY during R. 
solanacearum-infection—Pathogen infection 
induces the expression of several thioredoxins in 
Arabidopsis (36,47).  In particular, Trx-h5 plays 
an important role in plant defense as it was shown 
that Trx-h5 facilitates the reduction of NPR1 
disulfides to catalyze the oligomer-to-monomer 
switch, which in turn promotes the activation of 
SA-dependent plant defense (36).  Intriguingly, we 
found that Trx-h5 could most efficiently stimulate 
the GGCT activity of RipAY in vitro (Fig. 8E).  
Based on this observation, we speculate that 
RipAY is injected into the host plant cell via the 
T3SS apparatus as an inactive form and then 
converted to an active form by host eukaryotic 
thioredoxins, in particular Trx-h5 during R. 
solanacearum-infection and then degrade 
glutathione and other unknown γ-glutamyl 
compounds which together might prevent the 
activation of the host disease response (Fig. 10).  
Further analysis will be required for the 
understanding of the role of RipAY during R. 
solanacearum-infection at the molecular level.  
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FIGURE LEGENDS 
FIGURE 1. Expression of RipAY, but not other ChaC family proteins from various organisms, 
causes growth inhibition to yeast.  (A) Phylogenetic analysis of ChaC domain containing proteins from 
various organisms. The organisms, locus tag/gene name, and (GenbankTM Accession numbers) are as 
follows: Escherichia coli ChaC (L28709.1); Ralstonia solanacearum RSc0782(AL646052.1) and 
RSp1022/RipAY (AL646053.1); Acidovorax citrulli Aave_2801 (CP000512.1) and Aave_4606 
( CP000512.1); Pseudomonas syringae PSPT_05239 (AE016853.1); Saccharomyces cerevisiae 
YER163c/Gcg1 (NM_001179053.3); Aspergillus oryzae ChaC (XM_001818295.2); Homo sapiens ChaC1 
(NM_001142776.1) and ChaC2 (NM_001008708.2); Mus musculus ChaC1 (NM_026929.4) and ChaC2 
(NM_026527.3); Xenopus tropicalis ChaC1 (NM_001130284.1) and ChaC2 (NM_001017137.2); Gallus 
gallus ChaC1 (NM_001199656.1) and ChaC2 (AJ720918.1); Danio rerio ChaC1 (NM_001110126.1) and 
ChaC2 (BC154137.1); Arabidopsis thaliana AT5G26220/GGCT2;1 (BT005234.1), 
AT4G31290/GGCT2;2 (BT006411.1) and AT1G44790/GGCT2;3 (BT006192.1) (B) Schematic 
representation of putative domain organization of ChaC domain containing proteins from various 
organisms.  (C) Yeast growth inhibition assay showing serial dilutions of S. cerevisiae BY4743 cells 
grown under inducing (galactose) or noninducing (glucose) conditions that are carrying plasmids 
expressing the C-terminal GFP-tagged indicated proteins under the control of GAL1 promoter.  The cells 
were grown at 26°C for 2 days for SD (-Ura) and 3 days for SGal (-Ura).  (D, E) Detections of the ChaC 
domain-containing proteins expressed in yeast.  Yeast cells carrying the plasmids expressing GFP-tagged 
RipAY or other ChaC-proteins under the control of GAL1 promoter were grown in SD (-Ura) liquid 
medium to mid-log phase, then shifted to SGal (-Ura) liquid medium to induce the protein expression, 
further cultured for 12 h, and analyzed by (D) immunoblot with anti-GFP antibody or (E) fluorescence 
microscopy with native GFP fluorescence.  Glucose 6-phosphate dehydrogenase (G6PDH) was used as a 
loading control.  Scale bar = 5 µm 
 
FIGURE 2. Expression of RipAY in yeast causes growth inhibition by depletion of intracellular 
glutathione through its conserved ChaC domain.  (A) The GSH catabolism by a classical GGT- and 
GGCT-dependent and a novel ChaC family-dependent pathways, GGT: γ-glutamyl tranpeptidase, GGCT: 
γ-glutamyl cyclotransferase  (B) The RipAY protein was modeled using the Phyre2 server.  The homology 
model obtained was superimposed on the crystal structure of GGCT (C7orf24, PDB code 2PN7 and 
2RBH) using the graphics program CueMol.  Superimposition of homology-modeled RipAY structure 
(green color) on GGCT structure (blue color).  (C) Putative active site residues of RipAY (Y129LSL and 
E216, green color) were superimposed on corresponding active site residues of GGCT (Y22GSN and E98, 
blue color).  (D) Multiple alignment of amino acid sequences in the regions of putative substrate binding- 
and catalytic-sites of the class I and II ChaC proteins.  The conserved amino acids, Y129xSL and E216 are 
putative substrate binding-site and catalytic glutamate residue for GGCT, respectively.  (E) Protein 
A-tagged Gcg1, RipAY WT and active site mutant, E216Q were expressed in a glutathione degrading 
enzyme deficient strain (dug3∆ ecm38∆ gcg1∆ triple mutant) of yeast cells and immunopurified with 
IgG-beads.  The GGCT activity of the beads immobilized with Gcg1, RipAYWT or RipAYE216Q proteins, 
was measure by Dug1-coupled method as described in Experimental Procedures.  (F) The proteins 
extracted from the beads shown in (E) were resolved on SDS-PAGE followed by immunoblotting using a 
rabbit IgG.  (G) Mutations in putative substrate binding- and catalytic-sites of RipAY restore the yeast 
growth inhibition caused by expression of RipAY.  Yeast cells carrying empty vector or GAL1-expression 
vector of WT or indicated mutant proteins of RipAY were spotted on SD (-Ura) and SGal (-Ura) plates 
and cultured for 2 days and 3 days, respectively.  (H) Yeast cells carrying GAL1-epxression plasmid of 
GFP-tagged WT or indicated mutant proteins of RipAY were grown in SD (-Ura) liquid medium to 
mid-log phase and then shifted to SGal (-Ura) liquid medium to induce the protein expression, further 
cultured for 12 h, and analyzed by immunoblot with anti-GFP antibody.  (I) Mutations in putative 
substrate binding- and catalytic-sites of RipAY restore the reduction of intracellular GSH level in yeast 
caused by expression of RipAY.  The total GSH levels of the cell lysates from yeast cells expressing 
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indicated proteins were measured as described in Experimental Procedures.  Values represent the mean ± 
SEM (n≥3).   
 
FIGURE 3. Increased uptake of GSH does not rescue the growth inhibition effect caused by 
expression of RipAY. (A) Yeast wild-type and gsh1∆/gsh1∆ homozygote cells carrying indicated 
plasmids were spotted on SD (-ura) (OFF) or SGal (-leu, -ura) (ON) plates supplemented with the 
indicated concentration of GSH.  Cells were incubated at 26˚C for 2 days for SD (-leu, -ura) or 3 days for 
SGal (-leu, -ura).  (B) Yeast cells carrying indicated plasmids were spotted on SD (-leu, -ura) 
(RipAY-expression: OFF) or SGal (-leu, -ura) (RipAY-expression: ON) plates supplemented with the 
indicated concentration of GSH.  Cells were incubated at 26˚C for 2 days for SD (-leu, -ura) or 3 days for 
SGal (-leu, -ura).  RipAY or HGT1 were expressed under the control of a galactose-inducible GAL1 
promoter or a strong constitutive TEF1 promoter, respectively. (C) Yeast cells carrying indicated plasmids 
growing exponentially in SD (-leu, -ura) liquid medium were transferred to SGal (-leu, -ura) liquid 
medium and cultured at 26˚C for 19 h and then GSH (100 µM) was supplemented at 30 min prior to the 
termination of the culture.  (D) Yeast cells carrying indicated plasmids growing exponentially in SD (-leu, 
-ura) liquid medium were transferred to SGal (-leu, -ura) liquid medium supplemented with or without 
100 µM GSH and cultured at 26˚C for 19 h.  The total GSH levels of the cell lysates from yeast cells 
expressing indicated proteins were measured.  Values represent the mean ± SEM (n=4 for C and n=3 for 
D).   
 
FIGURE 4. The GSH level of eggplant leaves inoculated with R. solanacearum wild-type, RipAY- 
and T3SS-deficient strains.  (A) Necrotic lesions on eggplant leaf three days post-inoculation with R. 
solanacearum WT strain (WT), RipAY deficient strain (∆ripAY), or T3SS deficient strain (∆hrcU).  Mock 
indicates inoculation of buffer without bacteria as a control.  (B) The GSH level of total lysate extracted 
from eggplant leaves inoculated with the indicated R. solanacearum strains at one day post-inoculation 
was measured as described in Experimental Procedures.  Values represent the mean ± SEM (n≥7). 
**P<0.01, ***P<0.001, one-way ANOVA post test (Turkey’s multiple comparison test). 
 
FIGURE 5. RipAY exhibits GGCT activity in the presence of eukaryotic factor(s). 
(A) Purification of recombinant Gcg1 and RipAY proteins.  Recombinant His6-tagged Gcg1 and RipAY 
were expressed in E. coli and purified using Ni-NTA affinity chromatography.  Purified proteins were 
analyzed on SDS-PAGE with Coomassie blue staining.  (B) Measurement of GGCT activity of 
recombinant Gcg1 and RipAY purified from E. coli.  0.1 µg of Gcg1 and 1 µg of RipAY were incubated 
with 5 mM glutathione, the reactions were terminated at indicated time points, the released Cys-Gly 
dipeptides were digested with Cys-Gly dipeptidase Dug1 and then the released Cys was measured by 
acidic ninhydrin. (C) Effect of concentration of the yeast protein extract on activation of GGCT activity of 
RipAY.  The beads bound with RipAYWT or RipAYE216Q proteins expressed in E. coli were pre-incubated 
with different concentrations of native yeast protein extracted from a glutathione degrading enzyme 
deficient strain (dug3∆ ecm38∆ gcg1∆ triple mutant) for 2 h at 4°C and washed with the same buffer three 
times and then GGCT activity of the beads was measured by the Dug1-coupled method.  (D) The protein 
A-tagged RipAYWT and RipAYE216Q proteins extracted from the beads shown in (C) were resolved on 
SDS-PAGE and visualized by CBB staining.  (E) The GGCT activity of bacterially expressed RipAY-His6 
protein incubated with 10 µg protein of the cell lysates from R. solanacearum, S. cerevisiae, human 
cultured cell HeLa, A. thaliana, or egg plant S. melongena cells was measured by Dug1-coupled method.  
Values represent the mean ± SEM (n≥3). 
 
FIGURE 6. Identification of thioredoxin as a eukaryotic activator for GGCT activity of RipAY. (A) 
Biochemical purification of RipAY’s eukaryotic activator from yeast protein extracts by HiPrep DEAE FF 
16/10 ion exchange, HiPrep Butyl FF 16/10 hydrophobic interaction, and HiPrep 16/60 Sephacryl S-100 
HR gel filtration chromatography.  (B) Gel-filtration fractions surrounding activity were loaded onto a 
Tricine-SDS-PAGE gel, visualized by silver-staining.  (C) Gel bands of fractions 37-41 stained with 
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Coomassie brilliant blue were collected and in-gel digestion and following LC-MS/MS analysis identified 
yeast thioredoxins, Trx1 and Trx2 proteins as the activator.  Amino acid sequences of S. cerevisiae Trx1 
and Trx2 and their corresponding tryptic peptides identified by LC-MS/MS analysis were shown.  
 
FIGURE 7. Yeast thioredoxins can activate a GGCT activity of RipAY both in vivo and in vitro. (A) S. 
cerevisiae WT, trx3∆ single mutant, trx1/2∆ double mutant and trx1/2/3∆ triple mutant cells carrying 
plasmid expressing RipAY or Gcg1 under the control of Tet-off promoter were grown in noninducing 
(+Dox) or inducing (-Dox) conditions.  Yeast cells transformed with corresponding empty vector was 
used as a control.  The cells were grown at 26°C for 3 days for SD (-Ura, +Dox) and 4 days for SD (-Ura, 
-Dox). (B) The GGCT activity of bacterially expressed RipAY-His6 protein incubated with 10 µg protein 
of the cell lysates from indicated S. cerevisiae thioredoxin mutant cells was measured by the 
Dug1-coupled method.  Values represent the mean ± SEM (n≥3). (C) Bacterially expressed S. cerevisiae 
Trx1-His6 protein can activate the GGCT activity of bacterially expressed RipAY-His6 protein. 
 
FIGURE 8. Plant thioredoxins can bind to RipAY and activate GGCT activity of RipAY in an 
isoform-specific manner. (A) Yeast two-hybrid assay for interaction between RipAY and various 
thioredoxins on the plate with different stringency conditions.  RipAY WT (RipAYWT) and mutant form of 
RipAY (RipAYCS), in which the sole cysteine residue at position 333 was substituted by serine, were used 
as bait.  R. solanacearum TrxA (RsTrxA), S. cerevisiae Trx1 (ScTrx1), A. thaliana Trx-h2, -h3, -h5 
(AtTrx-h2, AtTrx-h3, and AtTrx-h5) and mutant form of  Trx-h5 (AtTrx-h5CS), in which active site 
cysteine residues at position 39 and 42 were substituted by serine, were used as prey. (B) Yeast cells 
carrying empty vector or GAL1-expression vector of WT, active site mutant E216Q or C333S mutant of 
RipAY were spotted on SD (-Ura) and SGal (-Ura) plates and cultured for 2 days and 3 days, respectively.  
(C) GGCT activity of the beads bound with protein A-tagged RipAYWT, RipAYE216Q or RipAYC333S 
proteins expressed in E. coli incubated with 1.6 µM AtTrx-h5-His6 protein was measured by the 
Dug1-coupled method.  Values represent the mean ± SEM (n=3).  (D) Protein A-tagged RipAYWT, 
RipAYE216Q and RipAYC333S proteins extracted from the beads shown in (C) were resolved on SDS-PAGE 
and visualized by CBB staining. (E) Effect of thioredoxin isoforms on activation of GGCT activity of 
RipAY.  The GGCT activity of RipAY incubated with various concentrations of thioredoxin isoforms was 
measured by the Dug1-coupled method. Values represent the mean ± SEM (n≥3).  (F) Phylogenetic 
analysis of thioredoxin isoforms from various organisms. The organisms, locus tag/gene name, and 
(GenbankTM Accession numbers) are as follows: R. solanacearum, RSc1188/RsTrxA (AL646052.1) and 
RSc0779/RsTrx (AL646052.1); E. coli, EcTrxA (M26133.1) and EcTrxC (U8594.1); H. sapiens, HsTxn1 
(JQ313905.1) and HsTxn2 (DQ891579.2); S. cerevisiae, YLR043C/ScTrx1 (NM_001181930.1), 
YGR209C/ScTrx2 (NM_001181338.3) and YCR083C/ScTrx3 (NM_001178789.1); A. thaliana, 
At3g51030/AtTrx-h1 (NM_114963.4), At5g39950/AtTrx-h2 (AY113052.1), At5g42980/AtTrx-h3 
(AY065098.1), At1g19730/AtTrx-h4 (BT004710.1), At1g45145/AtTrx-h5 (AY040028.1), 
At1g59730/AtTrx-h7 (BT0031540.1), At1g69880/AtTrx-h8 (BT003670.1) and At3g08710/AtTrx-h9 
(BT0011728.1)  
 
FIGURE 9. Enzyme kinetic analysis of activated RipAY and Gcg1. (A) Michaelis-Menten plot of 
Trx-h5-activated RipAY and (B) Gcg1 toward glutathione.  Gcg1 (0.8 µM) or RipAY (0.04 µM) in the 
presence of Trx-h5 (8 µM) was used for determination of kinetic parameters.  Different concentration of 
glutathione were used ranging from 0.5 mM to 20 mM.  Dug1-coupled assay was used for the study as 
described in experimental procedures.  Data of three independent experiments were analyzed by no-linear 
regression using GraphPad prism 6.0. 
 
FIGURE 10. A model depicting how the RipAY T3SS effector is activated by host 
eukaryotic-thioredoxins to trigger GGCT activity.  RipAY is injected into a host plant cell as an 
inactive form and then stimulated its GGCT activity by host eukaryotic thioredoxins, such as Trx-h5 to 
degrade glutathione and other unknown γ-glutamyl compound(s). 
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TABLE 1??Strains used in this study
Strain Genotype Reference or souce
BY4741
BY4742
BY4743
MTY654
MATa KLVƋOHXƋPHWƋXUDƋ
MATƠKLVƋOHXƋO\VƋXUDƋ
Research Genetics
Research Genetics
Research GeneticsBY4741/BY4742
BY4741 GXJƋ.DQ0;HFPƋ.DQ0;JFJƋ.DQ0; This study
MTY674 BY4741 WU[Ƌ.DQ0; 
MTY676
MTY678
BY4741 WU[Ƌ.DQ0; 
BY4741 WU[Ƌ.DQ0; This study
This study
This study
MTY680 BY4741 WU[Ƌ.DQ0;WU[Ƌ.DQ0; This study
MTY761 BY4741 WU[Ƌ.DQ0;WU[Ƌ.DQ0;WU[Ƌ.DQ0; This study
OE1-1
RK5081
RK7101
wild-type, pathogenic to tabacco, eggplant isolate
OE1-1 ƋKUF8
OE1-1 ƋULS$< This study
6DFFKDURP\FHVFHUHYLVLDH
5DOVWRQLDVRODQDFHDUXP
This study
25
AH109 0$7DWUSOHXXUDKLVJDOƋJDOƋ
/<6::*$/8$6-*$/TATA-HIS3 0(/ *$/8$6-*$/TATA$'(
85$::0(/8$60(/TATA/DF=
Clontech
Ȗ*OXWDP\OF\FORWUDQVIHUDVHDFWLYDWHGE\HXNDU\RWLFWKLRUHGR[LQV
21
JVKǻ/JVKǻ Research GeneticsBY4743 JVKƋ.DQ0;JVKƋ.DQ0;
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TABLE 2. S. cerevisiae plasmids used in this study
Plasmids Construct Reference or souce
pMT751
pMT830
URA3, ȝ, PGAL1-attR1-Cmr-ccdB-attR2-GFP
URA3, ȝ, Ptet-off-attR1-Cmr-ccdB-attR2-GFP
33
33
This study
This studypRE85 pMT751; URA3, ȝ, PGAL1-R. sonalacearum RipAY-GFP
pRE97 pMT751; URA3, ȝ, PGAL1-R. sonalacearum RSc0782-GFP
This studypRE98 pMT751; URA3, ȝ, PGAL1-H. sapiens Chac2-GFP
This studypRE99 pMT751; URA3, ȝ, PGAL1-P. syringae PSPTO_5239-GFP
This studypRE100 pMT751; URA3, ȝ, PGAL1-S. cerevisiae GCG1-GFP
This studypRE161 pMT751; URA3, ȝ, PGAL1-A. citrulli Aave_4606-GFP
This studypRE173 pMT751; URA3, ȝ, PGAL1-A. thaliana AT1G44790/GGCT2;3-GFP
This studypRE174 pMT751; URA3, ȝ, PGAL1-A. thaliana AT4G31290/GGCT2;2-GFP
This studypRE175 pMT751; URA3, ȝ, PGAL1-A. thaliana AT5G26220/GGCT2;1-GFP
pMT922 pMT830; URA3, ȝ, Ptet-off-GFP 33
This studypRE86 pMT751; URA3, ȝ, PGAL1-RipAYE216Q-GFP
This studypRE164 pMT751; URA3, ȝ, PGAL1-RipAY2Y129A-GFP
This studypRE165 pMT751; URA3, ȝ, PGAL1-RipAYL130A-GFP
This studypRE166 pMT751; URA3, ȝ, PGAL1-RipAYS131A-GFP
This studypRE167 pMT751; URA3, ȝ, PGAL1-RipAYL132A-GFP
This studypRE168 pMT751; URA3, ȝ, PGAL1-RipAYL130G-GFP
This studypSF38 pMT751; URA3, ȝ, PGAL1-RipAYC333S-GFP
pMT1373 URA3, ȝ, PGAL1-attR1-Cmr-ccdB-attR2-Protein A This study
This studypRE257 pMT1373; URA3, ȝ, PGAL1-S. cerevisiae GCG1-Protein A
This studypRE258 pMT1373; URA3, ȝ, PGAL1-RipAY-Protein A
This studypRE259 pMT1373; URA3, ȝ, PGAL1-RipAYE216Q-Protein A
pACT2 LEU2, ȝ, Yeast two hybrid GAL4 AD vector Clontech
pGBKT7 TRP1, ȝ, Yeast two hybrid GAL4 DNA-BD vector Clontech
This studypSF25 pGBKT7; TRP1, ȝ, PADH1-GAL4 DNA-BD-RipAYE216Q
This studypSF37 pGBKT7; TRP1, ȝ, PADH1-GAL4 DNA-BD-RipAYE216Q, C333S
This studypSF50 pMT731; LEU2, ȝ, PADH1-GAL4 AD-A. thaliana TRX h5
This studypSF51 pMT731; LEU2, ȝ, PADH1-GAL4 AD-A. thaliana TRX h5C39, 42S
This studypSF52 pMT731; LEU2, ȝ, PADH1-GAL4 AD-S. cerevisiae TRX1
This studypMT1416 pMT731; LEU2, ȝ, PADH1-GAL4 AD-R. solanacearum TrxA
pGADT7 LEU2, ȝ, Yeast two hybrid GAL4 AD vector Clontech
This studypRE249 pGADT7; LEU2, ȝ, PADH1-GAL4 AD-A. thaliana TRX h2
This studypRE250 pGADT7; LEU2, ȝ, PADH1-GAL4 AD-A. thaliana TRX h3
pMT731 pACT2; GAL4 AD-attR1-Cmr-ccdB-attR2 This study
Ȗ*OXWDP\OF\FORWUDQVIHUDVHDFWLYDWHGE\HXNDU\RWLFWKLRUHGR[LQV
22
pTEF1-416-HGT1 pRS416; URA3, CEN, PTEF1-S. cerevisiae HGT1 31
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TABLE 3. E. coli plasmids used in this study
Plasmids Construct Reference or souce
pMT1371 pET23d: PT7-attR1-Cm
r-ccdB-attR2-Protein A This study
pET23d Amp, PT7, the C-terminal His6-tag fusion vector Novagen, Inc
pSF17 pET23d: PT7-S. cerevisiae GCG1-His6 This study
pSF16 pET23d: PT7-R. solanacearum RipAY-His6 This study
pSF16 pET23d: PT7-R. solanacearum RipAY-His6 This study
pDEST17 Amp, PT7, the Gateway N-terminal His6-tag fusion vector Life Technologies
pSF40 pET23d: PT7-S. cerevisiae TRX1-His6 This study
pSF49 pDEST17: PT7-Met-His6-A. thaliana TRX h5 This study
pMT1409 pDEST17: PT7-Met-His6-A. thaliana TRX h2 This study
pMT1410 pDEST17: PT7-Met-His6-A. thaliana TRX h3 This study
pMT1411 pDEST17: PT7-Met-His6-A. thaliana TRX h5
C39, 42S This study
pMT1415 pDEST17: PT7-Met-His6-R. solanacearum TrxA This study
pRE254 pMT1371: PT7-S. crevisiae GCG1-ProteinA This study
pRE255 pMT1371: PT7-R. solanacearum RipAY-ProteinA This study
pRE256 pMT1371: PT7-R. solanacearum RipAY
E216Q-ProteinA This study
pMT1368 pMT1371: PT7-ProteinA This study
pMT1293 pET23d: PT7-S. cerevisiae DUG1-His6 This study
Ȗ*OXWDP\OF\FORWUDQVIHUDVHDFWLYDWHGE\HXNDU\RWLFWKLRUHGR[LQV
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Enzyme
Gcg1
RipAY*
kcat (s
-1)KM(mM)
kcat/KM
(s-1 mM-1)
1.23 ± 0.17
2.11 ± 0.17
0.33 ± 0.02
52.8 ± 9.58
0.27 ± 0.03
25.2 ± 1.22
Gcg1 AtGGCT2;2** AtGGCT2;3**
x 94.0 x 66.7 x 1081
5LS$<ZDVDFWLYDWHGE\ȝ0AtTrx-h5.
**Kumar et al.,  (29).
v.s. RipAY
Comparison of  kcat/KM value
TABLE 4  Kinetic Parameters of S. cerevisiae Gcg1 and  AtTrx-h5-activeted RipAY
Ȗ*OXWDP\OF\FORWUDQVIHUDVHDFWLYDWHGE\HXNDU\RWLFWKLRUHGR[LQV
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